| Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter … J Bilinski, K Lis, A Tomaszewska, P Grzesiowski, T Dzieciatkowski, ... American journal of hematology 96 (3), E88-E91, 2021 | 31 | 2021 |
| Kidney dysfunction after hematopoietic cell transplantation—Etiology, management, and perspectives D Jaguś, K Lis, L Niemczyk, GW Basak Hematology/oncology and stem cell therapy 11 (4), 195-205, 2018 | 19 | 2018 |
| Fecal microbiota transplantation with ruxolitinib as a treatment modality for steroid-refractory/dependent acute, gastrointestinal graft-versus-host disease: A case series J Biliński, M Jasiński, A Tomaszewska, K Lis, P Kacprzyk, L Chmielewska, ... American journal of hematology 96 (12), E461-E463, 2021 | 15 | 2021 |
| Eosinophilic gastroenteritis and graft‐versus‐host disease induced by transmission of Norovirus with fecal microbiota transplant J Bilinski, K Lis, A Tomaszewska, A Pechcinska, P Grzesiowski, ... Transplant Infectious Disease 23 (1), e13386, 2021 | 15 | 2021 |
| Predictive model for infection risk in myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia patients treated with azacitidine; azacitidine … K Mądry, K Lis, P Biecek, M Młynarczyk, J Rytel, M Górka, P Kacprzyk, ... Clinical Lymphoma Myeloma and Leukemia 19 (5), 264-274. e4, 2019 | 15 | 2019 |
| Cause of death and excess mortality in patients with lower‐risk myelodysplastic syndromes (MDS): A report from the European MDS registry K Mądry, K Lis, P Fenaux, D Bowen, A Symeonidis, M Mittelman, ... British Journal of Haematology 200 (4), 451-461, 2023 | 10 | 2023 |
| Supporting the diagnosis of Fabry disease using a natural language processing-based approach AA Michalski, K Lis, J Stankiewicz, SM Kloska, A Sycz, M Dudziński, ... Journal of Clinical Medicine 12 (10), 3599, 2023 | 7 | 2023 |
| Fresh Versus Frozen Stool for Fecal Microbiota Transplantation—Assessment by Multimethod Approach Combining Culturing, Flow Cytometry, and Next-Generation Sequencing J Bilinski, M Dziurzynski, P Grzesiowski, E Podsiadly, ... Frontiers in Microbiology 13, 872735, 2022 | 7 | 2022 |
| Low serum albumin level deteriorates prognosis in azacitidine-treated myelodysplastic syndromes patients–results of the PALG study ‘PolAZA’ K Mądry, K Lis, A Tukiendorf, P Szwedyk, K Kapelko-Słowik, E Subocz, ... Hematology 26 (1), 556-564, 2021 | 5 | 2021 |
| Diagnosis of myelodysplastic syndromes in Poland: Polish Adult Leukemia Group (PALG) 2021 recommendations K Mądry, J Drozd-Sokołowska, K Lis, BK Budziszewska, B Pogłódek, ... Acta Haematologica Polonica 53 (1), 3-18, 2022 | 4 | 2022 |
| Fecal microbiota transplantation as a treatment of severe steroid-resistant acute and chronic graft versus host disease. Spectrum of responses and complications J Bilinski, K Lis, A Tomaszewska, P Grzesiowski, A Pechcinska, ... Blood 134, 5667, 2019 | 3 | 2019 |
| Novel protocol for autologous HSCT in patients with high risk of complications: Ambulatory chemomobilization and transplantation of fresh hematopoietic stem cells with backup … E Snarski, AW Gajda, M Gorka, M Maciejewska, E Urbanowska, K Lis, ... BONE MARROW TRANSPLANTATION 54, 291-292, 2019 | 1 | 2019 |
| Excess mortality in low-risk MDS can be explained by MDS and AML related causes of death K Madry, G Yu, K Lis, P Fenaux, D Bowen, A Symeonidis, M Mittelman, ... Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018 | 1 | 2018 |
| PB1999: TOBACCO SMOKING IN MDS PATIENTS–ANALYSIS FROM THE MDS PALG REGISTRY R Machowicz, K Lis, J Rytel, A Jachalska, P Szwedyk, O Sosnia, E Wiater, ... HemaSphere 7 (S3), e2672439, 2023 | | 2023 |
| Treatment recommendations developed by MDS experts of the Polish Adult Leukemia Group (PALG) for management of myelodysplastic syndromes (MDSs) and other MDS-related conditions … K Mądry, BK Budziszewska, K Lis, J Drozd-Sokołowska, B Pogłódek, ... Acta Haematologica Polonica 53 (2), 75-93, 2022 | | 2022 |
| Rekomendacje ekspertów MDS PALG w zakresie diagnostyki zespołów mielodysplastycznych w Polsce na 2021 rok K Mądry, J Drozd-Sokołowska, K Lis, BK Budziszewska, B Pogłódek, ... Hematologia-Edukacja 2 (1), 1-18, 2022 | | 2022 |
| Evaluation of Intestinal Permeability in Candidates For Allohct And in Early Post-Transplant Period by Sugar Absorbtion Test: Interim Analysis of The Single-Center Prospective … M Tyszka, J Bilinski, L Chmielewska, P Kacprzyk, K Lis, A Tomaszewska, ... BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 305-306, 2021 | | 2021 |
| Impact of Abo Incompatibility on Complications of Allogeneic Hematopoietic Cell Transplantation-Retrospective, International, Multicenter Analysis by the Transplant … M Gorka, C Peczynski, E Polge, K Lis, R Niittyvuopio, HL Wallet, Z Peric, ... Bone Marrow Transplantation 55 (SUPPL 1), 583-584, 2020 | | 2020 |
| Novel Protocol for Autologous HSCT in Multiple Myeloma Achieves" Zero" Central Line associated Blood Stream Infections (CLABSI) E Snarski, A Tomaszewska, M Maciejewska, M Gorka, A Brodziak, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 561-562, 2020 | | 2020 |
| Characteristics and Outcomes of Patients with Lymphoma Who Developed Therapy-Related Acute Myeloid Leukemia or Myelodysplastic Syndrome-a Retrospective Analysis of the Polish … A Golos, K Mądry, K Lis, M Sobas, A Ożańska, M Czemerska, ... Blood 134, 5422, 2019 | | 2019 |
